Delivery Order SPE2DB22D3501-SPE2DB23FWU64
Award Date 8/9/23
Potential Completion Date 8/30/23
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $16,389.92 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO, a vaccine combination of 1,200-600mg-30,000 unit per 15ml. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance starting on July 11, 2023 and ending on August 1, 2023. No major subcontractors or set aside designations were indicated. The Defense Logistics Agency manages...
- The Defense Logistics Agency awarded a $40,974.80 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO, a vaccine product. Performance will take place in Conshohocken, Pennsylvania over a three week period concluding on August 22, 2023. The delivery order was issued against an unspecified multiple award contract vehicle to supply 1,200-600mg doses of PHESGO in 15ml vials for the Defense Logistics Agency's medical countermeasures program. No subcontractors or set aside...
- The Defense Logistics Agency awarded a $8,194.96 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO, a biosimilar vaccine. The contract calls for Amerisourcebergen to deliver 1,200-600mg doses of PHESGO in 30,000 unit vials to a location in Conshohocken, Pennsylvania by September 29, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure items...
- The Defense Logistics Agency awarded a $32,153.58 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO, a 600-600 mg-20,000 unit 10ml pharmaceutical product. The order was issued under an undisclosed multiple award contract vehicle and will be performed by Amerisourcebergen at its facility in Conshohocken, Pennsylvania by September 29, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency manages the global supply chain for...
- The Defense Logistics Agency (DLA) awarded a $17,256.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PHESGO 600-600 MG pharmaceutical products (20,000 units of 10ML vials), with performance at the company's Conshohocken, Pennsylvania location and an ultimate completion date of December 30, 2025. This competitive award, issued on December 8, 2025, carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,916.78 to AmerisourceBergen Drug Corp for PHESGO 600-600 mg pharmaceutical products (20,000 units of 10ml vials). This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The award was made on September 25, 2025, with an ultimate completion date of October 17, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of...
- Defense Logistics Agency awarded Amerisourcebergen Drug Corp a $16,352.79 firm fixed price delivery order for PHESGO 600-600 MG-20,000 UNIT 10ML with a completion date of November 9, 2023. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested pharmaceutical products from its Conshohocken, Pennsylvania location in support of Defense Logistics Agency programs. No set-aside provision was designated for this award issued under an unspecified pre-existing contract vehicle.
- The Defense Logistics Agency awarded a $25,000 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4562145639. The order is for 1,200-600mg doses of PHESGO, a medication supplied in 15ml vials, with a total of 30,000 units to be delivered. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, between September 12 and October 3, 2023. No subcontractors or set aside designations were identified. The Defense Logistics...
- The Defense Logistics Agency issued a $11,261.28 delivery order to Amerisourcebergen Drug Corp on February 10, 2026, for PHESGO 600–600 MG pharmaceutical product (20,000 units, 10 mL vials). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Place of performance is Conshohocken, PA. Ultimate...
- The Defense Logistics Agency issued a $5,630.64 delivery order to Amerisourcebergen Drug Corp on March 10, 2026, for PHESGO 600–600 mg pharmaceutical product (20,000 units of 10 ml vials). The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at up to $999,999,999.00 through December 2026), which provides global pharmaceutical and medical supply support to military healthcare programs. Place of performance is Conshohocken, PA. The ultimate completion date...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWU64Delivery Order
The Defense Logistics Agency awarded a $10,717.86 firm fixed price delivery order to Amerisourcebergen Drug Corporation for PHESGO, a 600-600 mg-20,000 unit 10ml vaccine. The contract will be performed in Conshohocken, Pennsylvania through August 30, 2023. DLA is the logistics combat support agency of the Department of Defense, responsible for worldwide logistics support in procurement, distribution and provision of medical supplies. No set-aside designation or subcontractors were indicated. The award is likely in support of DLA's mission to provide vaccines and other pharmaceuticals to military treatment facilities and beneficiaries.
Generated 12/21/23, 10:23 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/9/23 |